Back to Agendas
SHORTAGES CONSEQUENCES: THEIR IMPACT IN PATIENTS, HEALTH CARE PROFESSIONAL AND REGULATORS
Session Chair(s)
Pär Tellner, MPharm, MSc, RPh
Director, Regulatory, Drug development and Manufacturing
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
At this session we are focusing on consequences of shortages. Representatives for healthcare professionals and patients are - based on their experience - describing what could happen when it is not possible to deliver the medicinal products. A media representative is also giving their view on the level of transparency regarding shortages in Europe and the challenges to inform the public about this serious issue.
Speaker(s)
Consequences of shortages – HCP perspective
Roberto Frontini
Centre for Patient Safety Leipzig, Germany
Director of Pharmacy
Consequences of Shortages – patient perspective
François Houyez
European Organisation for Rare Diseases (EURORDIS), France
Treatment Information and Access Director, Health Policy Advisor
Consequence of Shortages – press perspective
Sten Stovall
Informa, United Kingdom
European Bureau Chief
Have an account?